dual glp-1/gip agonist Free Comparison Chart: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 Frontiers | GLP-1/GIP dual agonist
Description
They may also Read More GLP-1 Drugs and Cardiovascular Inflammation: A New Pathway for Risk Reduction
doi: 10.1016/j.cell.2019.10.031 5 BeekenR
If you were on 2.5 to 5mg tirzepatide, start retatrutide at 1mg weekly
A retrospective medical database analysis of T2D patients (n = 39,275) treated with exenatide or other glucose-lowering therapies (n = 381,218) indicated that the GLP-1 agonist might reduce in 19% the incidence of MACCE and in 12% cardiovascular hospitalizations [71]
Avraham SA, Hossein J, Somri F, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 126.Sourris KC, Ding Y, Maxwell SS, Al-Sharea A, Kantharidis P, Mohan M, et al
